LCG
RCKT icon

Lisanti Capital Growth’s Rocket Pharmaceuticals RCKT Stock Holding History

Lisanti Capital Growth’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-179,705
Closed -$7.96M – 161
2021
Q2 		$7.96M Buy
179,705
+27,287
+18% +$1.19M 0.99% 33
2021
Q1 		$6.76M Buy
152,418
+37,850
+33% +$2.08M 0.87% 50
2020
Q4 		$6.28M Buy
114,568
+31,560
+38% +$1.15M 0.87% 49
2020
Q3 		$1.9M Buy
+83,008
New +$2.05M 0.35% 88
2020
Q2 		– Sell
-38,910
Closed -$543K – 143
2020
Q1 		$543K Buy
38,910
+26,690
+218% +$529K 0.18% 107
2019
Q4 		$278K Buy
+12,220
New +$204K 0.07% 113

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return